Considered and approved the acquisition of 100% of paid-up equity share capital of HSDL Innovative Private Limited.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Hamps Bio's board has approved the acquisition of 100% paid-up equity share capital of HSDL Innovative Private Limited for a total cash consideration of about ₹2.04 crore. Post acquisition, HSDL will become a Wholly Owned Subsidiary of Hamps Bio. HSDL operates in freeze-drying of food, fruits, vegetables, herbs and ready-to-eat foods, with FY25 turnover of roughly ₹1.87 crore, showing steady growth from ₹1.45 crore in FY23. The transaction is classified as a related party deal since Hamps Bio's promoters and their relatives hold shares in the target company. The deal is expected to be completed within 60 days, and no government or regulatory approvals are required.
This small but strategic acquisition consolidates a related-party freeze-drying food business under Hamps Bio's umbrella, expanding its food processing vertical. While the deal size is modest, the related-party nature of the transaction may invite scrutiny from minority shareholders over fairness of pricing.